Animal Studies Show Path for Zika Virus Vaccine in Humans

Share this content:
Animal Studies Show Path for Zika Virus Vaccine in Humans
Animal Studies Show Path for Zika Virus Vaccine in Humans

FRIDAY, Aug. 5, 2016 (HealthDay News) -- Three vaccine platforms have demonstrated protective efficacy against Zika virus (ZIKV) challenge in rhesus monkeys, according to research published online Aug. 4 in Science.

Noting that the development of a safe and effective ZIKV vaccine is an urgent global priority, Peter Abbink, from Harvard Medical School in Boston, and colleagues investigated three vaccine platforms that have been developed in order to protect against ZIKV challenge in rhesus monkeys.

The researchers found that a purified inactivated virus vaccine was able to induce ZIKV-specific neutralizing antibodies, and provided complete protection for monkeys against ZIKV strains from Brazil and Puerto Rico. A second approach using purified immunoglobulin from vaccinated monkeys was able to confer passive protection in adoptive transfer studies. In a third approach, a plasmid DNA vaccine and single-shot recombinant rhesus adenovirus serotype 52 vector expressing ZIKV prM-Env was able to elicit neutralizing antibodies; this also provided complete protection for monkeys against ZIKV challenge.

"These data support the rapid clinical development of ZIKV vaccines for humans," the authors write.

Three authors are employees of BIOQUAL.

Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »


Sign up for myCME e-newsletters


Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

FDA Approves Zejula for Certain Female Cancers

FDA Approves Zejula for Certain Female Cancers

PARP inhibitor may help fight tumors affecting the ovaries, fallopian tubes, or peritoneum

USPSTF: Evidence Lacking for Celiac Dz Screen in Asymptomatic

USPSTF: Evidence Lacking for Celiac Dz Screen in ...

Insufficient evidence for weighing benefits, harms of screening for celiac disease in asymptomatic

Lap, Abdominal Hysterectomy Equal for Early Endometrial CA

Lap, Abdominal Hysterectomy Equal for Early Endometrial CA

Equivalent disease-free survival at 4.5 years for stage I endometrial cancer with TAH, TLH

is free, fast, and customized just for you!

Already a member?

Sign In Now »